Beractant
Records for this ingredient, by country (identity only).
ATC R07AA02 · 4 markets · 5 records
AU 2 records · 1 shown of 1
- 25 mg/mL per mL / per unit basis not statedliquidSURVANTA beractant (as phospholipids) 200mg/8mL suspension vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Survanta ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 25 mg per mL / per unit basis not statedliquidSurvanta
GB 1 records · 1 shown of 1
- 200 mg/8 mLliquidSurvanta 200mg/8ml endotracheopulmonary suspension bottles
CA 1 records · 1 shown of 1
- 25 mg per mL / per unit basis not statedliquidSurvanta
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.